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Abstract
Background—U.S. Hispanic women have high rates of parity, breastfeeding and obesity. It is 
unclear whether these reproductive factors are associated with breast cancer (BC) mortality. We 
examined the associations between breastfeeding, parity, adiposity and BC-specific and overall 
mortality in Hispanic and non-Hispanic white (NHW) BC cases.
Methods—The study population included 2,921 parous women (1,477 Hispanics, 1,444 NHWs) 
from the Breast Cancer Health Disparities Study with invasive BC diagnosed between 1995 and 
2004. Information on reproductive history and lifestyle factors was collected by in-person 
interview. Overall and stratified Cox proportional hazard regression models by ethnicity, parity, 
and body mass index (BMI) at age 30 years were used to calculate hazard ratios (HR) and 95% 
confidence intervals (CI).
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Results—After a median follow-up time of 11.2 years, a total of 679 deaths occurred. Pre-
diagnostic breastfeeding was associated with a 16% reduction in mortality (HR, 0.84; 95% 
0.72-0.99) irrespective of ethnicity. Parity significantly modified the association between 
breastfeeding duration and mortality (p-interaction= 0.05), with longer breastfeeding duration 
associated with lower risk among women who had ≤ 2 births (p-trend= 0.02). Breastfeeding 
duration was associated with reduced risk of both BC-specific and overall mortality among women 
with BMI < 25 kg/m2, while positive associations were observed among women with BMI ≥ 25 
kg/m2 (p-interactions < 0.01).
Conclusion—Pre-diagnostic breastfeeding was inversely associated with risk of mortality after 
BC, particularly in women of low parity or normal BMI. These results provide another reason to 
encourage breastfeeding and weight management among young women.
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Introduction
Hispanics are the largest and fastest growing minority group in the United States (U.S.) 
[1,2].While heart disease is the leading cause of death among all U.S. women, breast cancer 
(BC) is the leading cause of death among U.S. Hispanic women [3,4]. Compared to non-
Hispanic white (NHW) women, Hispanic women are more likely to be diagnosed with 
higher BC stage and with larger breast tumors [5]. They are also more likely to be diagnosed 
with estrogen receptor negative (ER-) tumors which have poor prognosis [6,7]. These BC 
disparities exist even after taking into consideration differences in demographic factors and 
breast cancer screening [5]. While BC risk factors have been extensively researched, our 
current understanding of factors that might influence BC prognosis is limited, especially for 
Hispanic women.
Parity and breastfeeding are well-established protective factors for BC development [8]. It is 
less clear whether these reproductive factors have the same impact on BC prognosis. 
Hispanic women have high parity and some studies reported that they are more likely to 
breastfeed compared to NHW women [9,10]. To date, only one prospective study has 
included Hispanic women in the evaluation of the association between reproductive factors 
and mortality among women diagnosed with BC [11]. Overall, results for the association 
between higher parity and BC-specific mortality have varied, with some studies reporting 
positive associations [12,13], inverse associations [14], or no association [15-17]. Findings 
from the few studies that have evaluated the relationship between breastfeeding and 
mortality among women diagnosed with BC have been inconsistent, with both inverse [11] 
and null [16,13,18,19] associations reported. The majority of women included in these 
studies were NHW cases.
Obesity has been found to be associated with lower survival of women diagnosed with BC 
[20-22]. Few studies have examined the impact of obesity during the reproductive years on 
BC-specific and overall mortality among BC survivors and neither of these studies found 
significant associations [23,24]. These studies did not include Hispanic women who have a 
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high prevalence of obesity [25]. We previously examined the associations between body 
mass index (BMI) at age 30 years and BC-specific and all-cause mortality among Hispanic 
and NHW invasive BC cases [26]. Among all women, obesity at age 30 years significantly 
increased risk of all-cause mortality [26]. However, when stratifying the analysis by 
ethnicity, obesity at age 30 was associated with increased risk of BC-specific mortality only 
among NHW women, with a significant interaction by ethnicity (p =0.045) [26]. Parity has 
been found to be associated with increased maternal weight gain, however the strength of 
this association may vary by other factors such as pre-pregnancy body weight and race/
ethnicity [27]. Additionally, obese mothers have lower rates of breastfeeding initiation [28]. 
The higher rates of obesity during the reproductive years among parous women could have 
an impact on BC prognosis.
We hypothesized that breastfeeding and adiposity could be important modifiable prognostic 
factors among parous Hispanic and NHW women diagnosed with BC. We examined the 
associations between breastfeeding, parity and BC-specific and overall mortality in Hispanic 
and NHW parous women with invasive BC from the Breast Cancer Health Disparities Study 
(BCHDS). We also evaluated if the associations differed by ethnicity, obesity measures at 
various ages, and tumor estrogen receptor (ER) status.
Methods
This analysis includes BC cases from two population-based case-control studies that were 
pooled for the BCHDS and had survival data available, the 4-Corners Breast Cancer Study 
(4-CBCS) and the San Francisco Bay Area Breast Cancer Study (SFBCS) (20). All 
participants signed informed written consent prior to participation. The study was approved 
by the Institutional Review Board for Human Subjects at each institution.
The 4-CBCS consists of NHW and Hispanic/Native American (NA) women aged 25 to 79 
years residing in Arizona, Colorado, New Mexico, and Utah at the time of diagnosis. Cases 
newly diagnosed with in situ or invasive BC between October 1999 and May 2004 were 
identified through the state-wide cancer registries [29]. A total of 852 Hispanic, 22 NA, and 
1,683 NHW BC cases completed an in-person interview in English or Spanish on BC risk 
factors and participated in the measurement of body size (height, weight, waist, and hip 
circumferences). The sample size of NA cases was too small for separate analysis; therefore, 
these women were combined with Hispanics. A total of 1,544 (560 Hispanics, 984 NHWs) 
parous, first primary invasive BC cases (stages I-IV) were included from the 4-CBCS with 
data on parity, breastfeeding history, survival status, and BC stage. The SFBCS included 
Hispanic, African American, and NHW women between the ages of 35 and 79 years from 
the San Francisco Bay Area [30,31]. Cases newly diagnosed with invasive BC (stages I-IV) 
between April 1995 and April 2002 were identified through the Greater Bay Area Cancer 
Registry. A total of 2,258 cases completed an in-person interview in English or Spanish on 
BC risk factors and body size measurements. A total of 1,377 (917 Hispanics, 460 NHWs) 
parous Hispanic or NHW cases were included from the SFBCS with data on parity, 
breastfeeding history, survival status, and BC stage.
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Information on estrogen and progesterone receptor (ER/PR) status and stage at diagnosis 
(Surveillance, Epidemiology, and End Results (SEER) summary stage) was obtained from 
the New Mexico, Utah, Colorado, Arizona, and California cancer registries. ER/PR status 
was available for 979 (68%) NHW cases and 958 (75%) Hispanic cases. Through linkage 
with the cancer registries we obtained information on vital status as of November 2013, 
including date of death or last follow-up (month and year). Survival (in months) was 
calculated as the difference between diagnosis date and date of death or last follow-up. The 
cause of death was classified as BC if either the primary or contributing cause of death noted 
on the death certificate was BC.
Interview data were harmonized across the studies [32]. The referent year was defined as the 
calendar year prior to BC diagnosis. Parity was defined as the number of live births and was 
categorized as 1 to 2, 3 to 4, 5 or more. Parity was also categorized as 1 to 2 vs 3 or more to 
conserve statistical power in stratified models. Nulliparous women were excluded from all 
analyses. History of breastfeeding was recorded in weeks for each live birth and was 
evaluated by weeks of lifetime breastfeeding duration, categorized as tertiles based upon the 
distribution among all cases, and was also categorized as ever vs. never.
Potentially confounding variables evaluated included age at BC diagnosis, self-reported 
ethnicity, study site, highest level of education (less than high school, high school graduate, 
and post high school), caloric intake per day in referent year, age at first and last birth, 
pregnancy duration in years (age at first birth subtracted from age at last birth), BMI at age 
30 years and in the referent year, waist circumference (WC), and waist-hip ratio (WHR). 
BMI in the referent year was calculated as self-reported weight (in kg) during the referent 
year (or more distantly recalled weight if referent year weight was not available or measured 
weight if neither were available) divided by measured height (in m) squared. The 4-CBCS 
asked about weight at age 30 years. Phase 1 of the SFBCS collected self-reported weight for 
the age range of 25 to 30 years, and for Phases 2 and 3, participants were asked about their 
weight for the age ranges of 20-29 years and 30-39 years. The weight reported for 25 to 30 
years in Phase 1 and the mean of the weights for Phases 2 and 3 for each age range were 
then harmonized with weight at age 30 from the 4-CBCS. BMI at age 30 was calculated as 
self-reported weight at age 30 (in kg) divided by measured height (in m) squared. Waist and 
hip circumference were measured post-diagnosis at the time of interview and converted to 
centimeters (cm); WHR was calculated as WC divided by hip circumference. All body size 
measures were modeled as continuous variables.
Descriptive statistics were calculated by ethnicity for parity, history of breastfeeding, and all 
potential confounders and chi-square tests and t-tests were used to compare distributions 
between ethnic groups. HRs and 95% CIs were calculated by Cox proportional hazards 
regression models for associations with mortality overall and BC-specific mortality, and by 
ethnicity, ER status, parity, and BMI at age 30. Interactions between parity and breastfeeding 
with ethnicity, ER status, BMI at age 30 and at referent year, WC and WHR were assessed 
using the likelihood-ratio test comparing the model including an interaction term with a 
reduced model without the term.
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The proportional hazards assumption was tested statistically using an interaction of main 
effects and covariates with the log of survival time. To correct these violations, we stratified 
models using the “STRATA” statement in SAS on variables that were found to be time 
dependent which included BC stage and age (only for the association between breastfeeding 
and all-cause mortality among all women by ER status). Strata-specific results are presented 
for those associations. Covariates included in multivariable models for BC-specific and all-
cause mortality were known prognostic factors that changed the point estimate for the main 
effect of parity or history of breastfeeding by ≥10% [33]. Final parity-mortality models were 
adjusted for age at diagnosis, ethnicity, stage, and study site and final breastfeeding-
mortality models were adjusted for these same covariates in addition to parity. A two-tailed 
probability value of ≤ 0.05 was considered statistically significant. All data analyses were 
performed using SAS version 9.4 (SAS Institute, Cary NC).
Results
After a median follow-up time of 11.2 years since BC diagnosis, a total of 679 deaths 
occurred, of which 352 deaths were due to BC. Table 1 presents the baseline characteristics 
of all parous BC cases (N=2,921) by ethnicity. A history of breastfeeding was reported by 
62.4% of Hispanic cases and 64.8% of NHW cases, with Hispanic women reporting longer 
duration of breastfeeding compared to NHW cases (p< 0.001). Hispanic cases were younger 
at first birth (mean= 23.3 years) compared to NHW cases (mean= 24.6 years); and were 
older at last birth (mean=30.5 years) compared to NHW cases (mean= 29.3 years). More 
Hispanic cases (17.4%) compared to NHW cases (7.7%) reported five or more births. 
Compared to NHW cases, Hispanic cases were younger at diagnosis (p=0.002) and more 
likely to be diagnosed with ER-/PR- tumors (p<0.001) (Table 1).
Overall, parity was not significantly associated with BC-specific or all-cause mortality in our 
study population (Table 2). However, among women with 5 or more births, our results were 
suggestive of positive associations among all women (HR, 1.25; 95% CI 0.99-1.57) and 
among Hispanic cases (HR, 1.35; 95% CI 0.99-1.85) for risk of all-cause mortality (Table 
2). No significant associations were observed between parity and mortality outcomes by ER 
status, WC, WHR, BMI during referent year, or BMI at age 30 (data not shown).
Breastfeeding was associated with reduced risk of overall mortality (HR, 0.84; 95% CI 
0.72-0.99) (Table 3); however, breastfeeding was not significantly associated with BC-
specific mortality (HR, 0.91; 95 % CI 0.77-1.14). When stratified by ethnicity, no significant 
associations were observed for either all-cause or BC-specific mortality (p-interaction > 
0.05) (Table 3). The statistical interaction between breastfeeding dichotomized as ever/never 
and parity was not statistically significant for BC-specific (p= 0.23) or all-cause (p= 0.11) 
mortality.
We observed significant reductions in risk of all-cause mortality among women who 
reported breastfeeding for 1 to 24 weeks (HR, 0.80; 95% CI 0.65-0.99) or for 24 to 69.9 
weeks (HR, 0.76; 95% CI 0.62-0.95), compared to women who never breastfed (Table 4). In 
stratified analysis by parity, we observed a significant reduction in risk of all-cause mortality 
among women that reported 1 to 2 births and that breastfed for ≥ 69.6 weeks (HR, 0.62; 95% 
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CI 0.40-0.97) with a significant trend (p=0.02). In contrast, breastfeeding among women that 
reported 3 or more births was only protective for women that breastfed for 1 to 24 weeks 
(HR, 0.72; 95% CI 0.53-0.98) or for 24 to 69.9 weeks (HR, 0.72; 95% CI 0.52-0.99). 
Breastfeeding for 69.6 weeks or longer was not associated with a reduction in mortality 
among all women or among women that reported 3 or more births. Parity was found to be a 
significant effect modifier for both BC-specific (p-interaction= 0.04) and all-cause (p-
interaction=0.05) mortality. Breastfeeding duration in weeks was not significantly associated 
with BC-specific mortality (Table 4).
Table 5 presents associations between breastfeeding, BC-specific and all-cause mortality by 
ER status. There were no significant associations between breastfeeding, BC-specific and 
all-cause mortality among women with ER+ breast tumors. However, borderline inverse 
associations with history of breastfeeding were found for both BC-specific (HR, 0.66; 95 % 
CI 0.41-1.05) and all-cause (HR, 0.72; 95% CI 0.50-1.04) mortality among women with ER- 
breast tumors.
BMI at age 30 years was the only obesity measure to result in significant statistical 
interactions with a history of breastfeeding for BC-specific (p interaction = 0.01) and all-
cause (p interaction=0.001) mortality (Table 6). Breastfeeding was significantly associated 
with reduced risk of BC-specific (HR, 0.70; 95 % CI 0.53-0.92) and all-cause (HR, 0.68; 
95% CI 0.56-0.83) mortality among women with normal BMI (< 25 kg/m2); while we did 
not observe significant statistical trends between breastfeeding duration and BC-specific (p-
trend=0.29) and all-cause (p-trend=0.98) mortality (Table 6). Among cases with BMI ≥ 30 
kg/m2 at age 30, we observed nonsignificant positive associations between breastfeeding and 
BC-specific (HR, 1.67; 95% CI 1.00-2.80) and all-cause (HR, 1.38; 95% CI 0.97-1.97) 
mortality. Furthermore, breastfeeding for 69.6 weeks or longer was associated with 
increased risk of BC-specific (HR, 2.02; 95% CI 1.10-3.70; p-trend= 0.04) and all-cause 
(HR, 1.79; 95% CI 1.18-2.73; p-trend= 0.002) mortality among overweight/obese women at 
age 30 years, with significant dose responses. We observed a statistically significant 
interaction between breastfeeding duration and BMI at age 30 for all-cause mortality (p 
interaction= 0.003); while the interaction between breastfeeding duration and BMI at age 30 
was not significant for BC-specific mortality (p interaction= 0.055).
Discussion
In this study population, Hispanic women had higher parity and a higher prevalence of 
obesity at age 30 years, compared to NHW women. The prevalence of breastfeeding for all 
women was 63.6% and was not significantly different by ethnicity; however, Hispanic cases 
did report breastfeeding for a longer duration compared to NHW cases. Breastfeeding was 
associated with reduced risk of overall mortality, but was not associated with BC-specific 
mortality. We observed a statistically significant interaction between breastfeeding and BMI 
at age 30 for BC-specific and all-cause mortality. We did not observe a significant 
association between parity and mortality outcomes; however parity significantly modified 
the association between breastfeeding duration and mortality. Breastfeeding among women 
with normal BMI at age 30 was associated with a 30% reduction in BC-specific mortality, 
while being overweight or obese at age 30 and breastfeeding for 69.6 weeks or longer was 
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associated with increased risk of both BC-specific and all-cause mortality. Associations 
between breastfeeding and mortality outcomes by ER status were not statistically significant, 
although results for women with ER- tumors were suggestive of inverse associations. Lastly, 
ethnicity did not modify the associations between parity, breastfeeding and mortality in our 
study population.
A recent analysis from two prospective BC cohorts by Kwan and colleagues found an 
inverse association between ever breastfeeding and BC-specific mortality (HR, 0.72; 95% CI 
0.53 – 0.98) [11]; this study did include Hispanics (8.7% of the study population), however, 
results were not reported by race/ethnicity. Our overall results for a history of breastfeeding 
were similar to the results from Kwan et al. Other studies that evaluated the relationship 
between breastfeeding and all-cause mortality among women diagnosed with BC have 
reported null associations [16,13,18,19]. Unlike those previous studies, we explored the 
modifying effect of parity on the association between breastfeeding and mortality, and found 
a significant statistical interaction between breastfeeding duration and parity. Therefore, it is 
possible that in prior studies the inverse associations between breastfeeding duration and 
mortality could have been indiscernible due to the complex relationship between BMI, 
parity, and breastfeeding duration, resulting in null associations. We believe the parity 
interaction results in our study are driven by the Hispanic women who have high parity 
(17% with 5 or more births), long breastfeeding duration (mean= 71 weeks), and high BMI 
at age 30.
The biological mechanisms of how breastfeeding prior to BC diagnosis affects survival are 
uncertain. Proliferative expansion of progenitor cells in the breasts occurs during pregnancy, 
and breastfeeding reduces this expansion by terminal differentiation of epithelial cells in the 
lobules with reducing the mammary epithelium proliferative activity [11,34]. The malignant 
transformation of the differentiated progenitor cells might lead to tumor subtypes that are 
more differentiated (i.e., ER+/PR+) instead of those that are undifferentiated (i.e., ER-/PR- 
tumors). Lack of breastfeeding could preserve the progenitor cells in their undifferentiated 
state inside the breast lobules, then the malignant transformation of these progenitor cells 
would result in undifferentiated ER- breast tumors which have poorer prognosis versus the 
differentiated ER+ tumors [11,35]. It is therefore plausible that breastfeeding initiation could 
either promote or prevent specific types of BC. The findings from our study support this 
mechanism, particularly for women diagnosed with ER- BC.
Reportedly, obese mothers are less likely to breastfeed [28]. Interestingly, in our study 
population with a high prevalence of breastfeeding, we did not observe any differences in 
breastfeeding duration by obesity status at age 30 years, which is close to the average age of 
last birth for parous women in our study. We did detect a statistical interaction between BMI 
at age 30 and breastfeeding with associations for both BC-specific and all-cause mortality. 
To the best of our knowledge, no other study has reported on this interaction. From our 
findings, we postulate that normal weight women at age 30 receive the benefits of 
breastfeeding by stimulating breast progenitor cells to reach their differentiated state, while 
the increased mortality risk associated with being overweight may provide a hormonal 
environment conducive for promoting tumor initiation among these actively dividing cells. 
These interesting observations should be further evaluated in larger study populations.
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Our findings for the associations between parity and mortality outcomes that were not 
significant are similar to results that have been observed in other epidemiological studies 
[15-17]. However, these same studies and others have found that a recent pregnancy or birth 
prior to BC diagnosis was associated with increased mortality. In a study conducted by 
Kroman et al., a recent pregnancy that occurred 2 years or less prior to BC diagnosis was 
associated with increased risk of all-cause mortality (relative risk, 1.58; 95% CI 1.24-2.02) 
[36]. Whiteman et al. found that among women aged 20-45 years whose last birth was 12 
months or less prior to their BC diagnosis were at increased risk of overall mortality (HR, 
1.62; 95 % CI 1.10-2.37) compared with nulliparous women [16]. We were unable to 
examine the association between recent birth and mortality outcomes due to the older age of 
the study population, with a mean age at diagnosis of 55 years. Moreover, only 39 women in 
our analytical study population had their last birth 2 years prior to their BC diagnosis and 
exclusion of these cases did not alter our findings.
Our study has several strengths and limitations. This is one of the first studies to evaluate the 
effects of reproductive factors on BC mortality in a large sample of Hispanics (51% of study 
population). We examined the interaction effects of multiple obesity measures, including 
BMI at age 30, BMI one year prior to diagnosis, WC, and WHR with parity and 
breastfeeding history. Additionally, our study has over 10 years of follow-up since BC 
diagnosis. We were also able to evaluate the effects of other reproductive factors as 
covariates, including age at menarche, menopausal status, age at first and last birth, and 
overall pregnancy duration. Also, BC cases from our study population that reported ever 
breastfeeding were not significantly different from cases that did not breastfeed based on 
clinical prognostic markers, including ER/PR and BC stage. As mentioned, one factor of 
interest that we were unable to examine was recent pregnancy. We were unable to further 
stratify the association between breastfeeding duration, parity, and mortality outcomes by 
ethnicity due to sample size constraints. As with past survival analyses using the BCHDS 
data, we were unable to adjust for BC treatment and mammography as those data were not 
available. In a recent report, we conducted sensitivity analyses in an effort to adjust for these 
factors, and concluded that adjustment for these factors did not alter the associations 
between BMI at age 30 years and mortality [26].
Our study results support the hypothesis that breastfeeding prior to the development of BC 
may be associated with lower risk of mortality. However, the association between 
breastfeeding duration and mortality is complex, and both parity and BMI should be 
considered when evaluating this relationship. In this study, inverse associations with ever 
breastfeeding were limited to women with normal BMI during their reproductive years. With 
the increasing rates of obesity, these results provide another reason to encourage 
breastfeeding and weight management among young women.
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